Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups.

Saved in:

Bibliographic Details
Journal Title:	Journal of Clinical Oncology
Authors and Corporations:	Zimmer, Lisa, Eigentler, Thomas K., Vaubel, Julia-Marianne, Mohr, Peter, Jradi, Zeinab, Kiecker, Felix, Utikal, Jochen, Berking, Carola, Kämpgen, Eckhart, Hauschild, Axel, Dippel, Edgar, Rompel, Rainer, Fluck, Michael, Stadler, Rudolf, Herbst, Rudolf, Terheyden, Patrick, Garbe, Claus, Loquai, Carmen, Schadendorf, Dirk
In:	Journal of Clinical Oncology, 32, 2014, 15_suppl, p. 9031-9031
Type of Resource:	E-Article
Language:	English
published:	American Society of Clinical Oncology (ASCO)
Subjects:	Cancer Research Oncology

Internet